IUD Arrangement

• US 4,233,968 A
• Filed: 07/26/1978
• Issued: 11/18/1980
• Est. Priority Date: 07/26/1978
• Status: Expired due to Term

• Current Assignee: Seth T. Shaw Jr
• Original Assignee: Seth T. Shaw Jr
• Inventors: Shaw, Seth T. Jr.
• Primary Examiner(s): Rosenbaum, C. Fred
• Application Number:
  US05/928,093
• Time in Patent Office: 846 Days
• Field of Search: 128/127, 128/129, 128/130, 128/260-261, 128/268, 424/16, 424/19, 424/294, 424/320, 424/324, 424/326
• US Class Current: 128/833
• CPC Class Codes: A61F 6/16 inflatable

Abstract

An intrauterine device of the type having an external surface contacting the walls of the uterus after insertion therein, and said device having first walls defining a fluid receiving cavity in at least a portion thereof. A concentrated fluid solution of a drug is present in the cavity and the drug is of the type providing an antifertility and antiproteolytic effect and is selected from the group consisting of aromatic monoamidines, aromatic diamidines and non-aromatic diamidines.

Claims

1. In an intrauterine device of the type insertable in the uterus and having a surface contacting the uterus and first walls defining a fluid receiving cavity in at least a portion thereof, the improvement comprising, in combination:

one of a concentrated fluid solution and suspension of a drug in said cavity and said drug of the type providing an antifibrinolytic, an antifertility and an antiproteolytic effect and said drug comprising an amidine; and

said first walls of said intrauterine device comprising a polymer having a predetermined permeability to said drug,

whereby, said predetermined permeability of said first walls controls the release rate of said drug from said cavity.

2. The arrangement defined in claim 1 wherein:

said first walls are semi-flexible.

3. The arrangement defined in claim 1 wherein:

said first walls define an inflatable cavity.

4. The arrangement defined in claim 1 wherein:

said drug is selected from the class consisting of aromatic monoamidines, aromatic diamidines and non-aromatic diamidines.

5. The arrangement defined in claim 1 and further comprising:

a coating on at least a portion of said surface of said intrauterine device, and said coating comprising one of a biodegradable cross-linked polymer and co-polymer of a drug selected from the same group as said drug in said cavity.

6. The arrangement defined in claim 1 and further comprising:

a coating on at least some of said surfaces of said intrauterine device, and said coating comprising one of a non-biodegradable monomer, dimer, oligomer and cross-linked polymer of a drug selected from the same group as said drug in said cavity.

7. The arrangement defined in claim 2 wherein:

said drug is selected from the class consisting of aromatic monoamidines, aromatic diamidines and non-aromatic diamidines.

8. The arrangement defined in claim 2 and further comprising:

a coating on at least a portion of said surface of said intrauterine device, and said coating comprising one of a biodegradable cross-linked polymer and co-polymer of a drug selected from the same group as said drug in said cavity.

9. The arrangement defined in claim 2 and further comprising:

a coating on at least some of said surfaces of said intrauterine device, and said coating comprising one of a non-biodegradable monomer, dimer, oligomer and cross-linked polymer of a drug selected from the same group as said drug in said cavity.

10. The arrangement defined in claim 3 wherein:

said drug is selected from the class consisting of aromatic diamidines of the group ##STR9## in which each amidine group ##STR10## may be substituted in either a meta or para position with respect to R₁

R₁ is selected from the group consisting of C_x H_y ; and

R₂ and R₃ are selected from the group consisting of hydrogen, chlorine, bromine, iodine, hydroxyl group and alkyl groups; and

##STR11## represents the benzene ring.

11. The arrangement defined in claim 3 wherein:

said drug is selected from the class consisting of;

3,8-Di (m-amidinophenyldiazoamino)-5-ethyl-6-phenylphenanthridinium chloride dihydrochloride hydrate

8-m(m-Amiophenyldiazoamino)-3-amino-5-ethyl-6-phenylphenanthridinium chloride,

1,4-di (p-amidinophenoxy) cyclohexane, and

1,4-di (2 amidinovinyl) cyclohexane.

12. The arrangement defined in claim 3 wherein:

said drug also provides a reversible anti-conceptive effect.

13. The arrangement defined in claim 3 and further comprising:

a coating on at least a portion of said surface of said intrauterine device, and said coating comprising one of a biodegradable cross-linked polymer and co-polymer of a drug selected from the same group as said drug in said cavity.

14. The arrangement defined in claim 3 and further comprising:

a coating on at least some of said surfaces of said intrauterine device, and said coating comprising one of a non-biodegradable monomer, dimer, oligomer and cross-linked polymer of a drug selected from the same group as said drug in said cavity.

15. The arrangement defined in claim 7 wherein:

said drug is selected from the class consisting of aromatic diamidines of the group ##STR12## in which each amidine group ##STR13## may be substituted in either a meta or para position with respect to R₁

R₁ is selected from the group consisting of C_x H_y ; and

R₂ and R₃ are selected from the group consisting of hydrogen, chlorine, bromine, iodine, hydroxyl group and alkyl groups; and

##STR14## represents the benzene ring.

16. The arrangement defined in claim 7 wherein:

said drug is selected from the class consisting of;

3,8-Di (m-amidinophenyldiazoamino)-5-ethyl-6-phenylphenanthridinium chloride dihydrochloride hydrate

8-m(m-Aminophenyldiazoamino)-3-amino-5-ethyl-6-phenylphenanthridinium chloride,

1,4-di (p-amidinophenoxy) cyclohexane, and

1,4-di (2 amidinovinyl) cyclohexane.

17. The arrangement defined in claim 13 wherein:

said drug is selected from the class consisting of aromatic diamidines of the group ##STR15## in which each amidine group ##STR16## may be substituted in either a meta or para position with respect to R₁

R₁ is selected from the group consisting of C_x H_y ; and

R₂ and R₃ are selected from the group consisting of hydrogen, chlorine, bromine, iodine, hydroxyl group and alkyl groups; and

##STR17## represents the benzene ring.

18. The arrangement defined in claim 13 wherein:

said drug is selected from the class consisting of;

3,8-Di (m-amidinophenyldiazoamino)-5-ethyl-6-phenylphenanthridinium chloride dihydrochloride hydrate

8-m(m-Amiophenyldiazoamino)-3-amino-5-ethyl-6-phenylphenanthridinium chloride,

1,4-di (p-amidinophenoxy) cyclohexane, and

1,4-di (2 amidinovinyl) cyclohexane.

19. The arrangement defined in claim 13 wherein:

said drug is selected from the class consisting of aromatic monoamidines, aromatic diamidines and non-aromatic diamidines.

20. The arrangement defined in claim 13 wherein:

said drug also provides a reversible anti-conceptive effect.

21. The arrangement defined in claim 13 further comprising:

a coating of copper on a portion of the surface of said body member.

22. The arrangement defined in claim 14 wherein:

said drug is selected from the class consisting of aromatic diamidines of the group ##STR18## in which each amidine group ##STR19## may be substituted in either a meta or para position with respect to R₁

R₁ is selected from the group consisting of C_x H_y ; and

R₂ and R₃ are selected from the group consisting of hydrogen, chlorine, bromine, iodine, hydroxyl group and alkyl groups; and

##STR20## represents the benzene ring.

23. The arrangement defined in claim 14 wherein:

said drug is selected from the class consisting of;

3,8-Di (m-amidinophenyldiazoamino)-5-ethyl-6-phenylphenanthridinium chloride dihydrochloride hydrate

8-m(m-Amiophenyldiazoamino)-3-amino-5-ethyl-6-phenylphenanthridinium chloride,

1,4-di (p-amidinophenoxy) cyclohexane, and

1,4-di (2 amidinovinyl) cyclohexane.

24. The arrangement defined in claim 14 wherein:

said drug is selected from the class consisting of aromatic monoamidines, aromatic diamidines and non-aromatic diamidines.

25. The arrangement defined in claim 14 wherein:

said drug also provides a reversible anticonceptive effect.

26. The arrangement defined in claim 16 further comprising:

a coating of copper on a portion of the surface of said body member.

27. In an intrauterine device of the type insertable in the uterus and having a surface contacting the uterus and first walls defining a fluid receiving cavity in at least a portion thereof, the improvement comprising, in combination:

a drug in said cavity and said drug of the type providing an antifibrinolytic, an antifertility and an antiproteolytic effect and said drug comprising an amidine; and

said walls of said intrauterine device comprising a polymer having a predetermined permeability to said drug,

whereby, said predetermined permeability of said first walls controls the release rate of said drug from said cavity.

28. The arrangement defined in claim 27 wherein:

said first walls are semi-flexible.

29. The arrangement defined in claim 28 wherein:

said drug is in a crystalline form.

30. The arrangement defined in claim 28 wherein:

said drug is in the form of a paste.

31. The arrangement defined in claim 28 further comprising:

a coating of copper on a portion of the surface of said body member.

32. The arrangement defined in claim 28 wherein said drug is selected from the group consisting of aromatic monoamidines, aromatic diamidines and non-aromatic diamidines.